跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TAMSULOSINA ARISTO 0,4 MG CAPSULAS DURAS DE LIBERACION MODIFICADA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
TAMSULOSINA ARISTO 0,4 MG CAPSULAS DURAS DE LIBERACION MODIFICADA EFG
Approved
STANDARD
TAMSULOSINA ARISTO 0,4 MG CAPSULAS DURAS DE LIBERACION MODIFICADA EFG
Aristo Pharma Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 12, 2024
Approval ID
1aa1aabf2c1a95e7
Company
Aristo Pharma Gmbh
Type
Standard
Approval Details
Approval Id
1aa1aabf2c1a95e7
Drug Cima Aemps Name
TAMSULOSINA ARISTO 0,4 MG CAPSULAS DURAS DE LIBERACION MODIFICADA EFG
Register Number
89697
Holder Company Name
Aristo Pharma Gmbh
Marketing Company Name
Aristo Pharma Iberia S.L.
Holder Company Detail Path
/organization/aristo-pharma-gmbh
Authorization Date
2024-07-12
Dosage Form
CÁPSULA DURA DE LIBERACIÓN MODIFICADA
Dose
0,4 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Aristo Pharma Gmbh
Company Detail Path
/organization/aristo-pharma-gmbh
Company Information
Pharmaceutical Company Name
Aristo Pharma GmbH
Country Name
Germany
Website
http://www.aristo-pharma.de
Active Ingredients
TAMSULOSINA HIDROCLORURO
0,4 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 12, 2024
Approval ID
1aa1aabf2c1a95e7
Type
Standard
Back to CIMA-AEMPS Approvals